BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31821710)

  • 1. Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice.
    Zhou Z; Qi J; Zhao J; Lim CW; Kim JW; Kim B
    J Cell Mol Med; 2020 Jan; 24(2):1383-1398. PubMed ID: 31821710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
    Zhou Z; Qi J; Lim CW; Kim JW; Kim B
    Toxicology; 2020 Nov; 444():152579. PubMed ID: 32905826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell.
    He Q; Xia X; Yao K; Zeng J; Wang W; Wu Q; Tang R; Zou X
    Life Sci; 2019 Dec; 239():117010. PubMed ID: 31672578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlexanox ameliorates acetaminophen-induced acute liver injury by reducing oxidative stress in mice.
    Qi J; Zhou Z; Lim CW; Kim JW; Kim B
    Toxicol Appl Pharmacol; 2019 Dec; 385():114767. PubMed ID: 31697998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.
    Möller M; Wasel J; Schmetzer J; Weiß U; Meissner M; Schiffmann S; Weigert A; Möser CV; Niederberger E
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.
    Beyett TS; Gan X; Reilly SM; Gomez AV; Chang L; Tesmer JJG; Saltiel AR; Showalter HD
    Bioorg Med Chem; 2018 Nov; 26(20):5443-5461. PubMed ID: 30270002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TBK1 by amlexanox attenuates paraquat-induced acute lung injury.
    Wang N; Li Y; Wang X; Ma Z; Wang Y; Zhang C; Yuan Y; Zhao M
    Toxicology; 2020 Oct; 443():152555. PubMed ID: 32763286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.
    Reilly SM; Abu-Odeh M; Ameka M; DeLuca JH; Naber MC; Dadpey B; Ebadat N; Gomez AV; Peng X; Poirier B; Walk E; Potthoff MJ; Saltiel AR
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
    Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKK
    Beyett TS; Gan X; Reilly SM; Chang L; Gomez AV; Saltiel AR; Showalter HD; Tesmer JJG
    Mol Pharmacol; 2018 Oct; 94(4):1210-1219. PubMed ID: 30082428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
    Cruz VH; Arner EN; Wynne KW; Scherer PE; Brekken RA
    Mol Metab; 2018 Oct; 16():139-149. PubMed ID: 29935921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Prolyl-Hydroxylase 1 Protects against Biliary Fibrosis via Attenuated Activation of Hepatic Stellate Cells.
    Strowitzki MJ; Kirchberg J; Tuffs C; Schiedeck M; Ritter AS; Biller M; Harnoss JM; Lasitschka F; Schmidt T; Radhakrishnan P; Ulrich A; Schneider M
    Am J Pathol; 2018 Dec; 188(12):2826-2838. PubMed ID: 30248340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of κB kinase α/inhibitor of κB-α/nuclear factor-κB pathway.
    Ping J; Gao AM; Qin HQ; Wei XN; Bai J; Liu L; Li XH; Li RW; Ao Y; Wang H
    J Pharmacol Exp Ther; 2011 Nov; 339(2):694-703. PubMed ID: 21862660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.
    Oral EA; Reilly SM; Gomez AV; Meral R; Butz L; Ajluni N; Chenevert TL; Korytnaya E; Neidert AH; Hench R; Rus D; Horowitz JF; Poirier B; Zhao P; Lehmann K; Jain M; Yu R; Liddle C; Ahmadian M; Downes M; Evans RM; Saltiel AR
    Cell Metab; 2017 Jul; 26(1):157-170.e7. PubMed ID: 28683283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amlexanox attenuates LPS-induced neuroinflammatory responses in microglial cells via inhibition of NF-κB and STAT3 signaling pathways.
    Phan Van T; Huyen Ton Nu Bao T; Leya M; Zhou Z; Jeong H; Lim CW; Kim B
    Sci Rep; 2024 Feb; 14(1):2744. PubMed ID: 38302598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis.
    Zhao P; Sun X; Liao Z; Yu H; Li D; Shen Z; Glass CK; Witztum JL; Saltiel AR
    JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35917178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.
    Reilly SM; Chiang SH; Decker SJ; Chang L; Uhm M; Larsen MJ; Rubin JR; Mowers J; White NM; Hochberg I; Downes M; Yu RT; Liddle C; Evans RM; Oh D; Li P; Olefsky JM; Saltiel AR
    Nat Med; 2013 Mar; 19(3):313-21. PubMed ID: 23396211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1.
    Mowers J; Uhm M; Reilly SM; Simon J; Leto D; Chiang SH; Chang L; Saltiel AR
    Elife; 2013 Dec; 2():e01119. PubMed ID: 24368730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.